An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)
N/A
The goal of this European observational study (Frane, Spain, italy, Spain a...
Status
Completed
Location
Institut du Cancer de Montpellier - Val d'Aurelle
Start Date
2024-11-22
Trial ID
NCT06690489
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2
The purpose of this study is to further advance the ability to practice per...
Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
N/A
Minimally interventional study on prevalence of emerging ESR1 mutations in ...